Our extensive global network of manufacturing facilities in geographically diverse locations across 6 continents support our efforts to ensure reliable supply, and our facilities are routinely inspected by stringent health authorities from around the world. Viatris operates approximately 40 manufacturing sites globally.

In Europe, we operate 11 manufacturing plants and 6 R&D facilities across 6 countries - France, Germany, Hungary, Ireland, Italy, and the UK. At these sites, a combined 3.500 employees work to develop, produce, and package a range of products destined for European and global markets. This includes oral solid dosage medicines, complex dosage forms, dermatologics, injectables, API (active pharmaceutical ingredients), food supplements, and medical devices.